VESNA RAJAK-HODZIC: Open Payments
NPI 1245656214 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 13 payments from 8 companies in 2025. Trend: 2023 $94 · 2024 $110 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 4 | $101 |
| Amgen Inc. | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| ABBVIE INC. | 1 | $27 |
| Boston Scientific Corporation | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: ZENPEP, UBRELVY, WATCHMAN FLX, OTEZLA, NEXLIZET, PAXLOVID, Rybelsus, NEXLETOL.
Industry payments across AZ — which companies pay providers there.
